Quick Takeaways
- Adage Capital Management, L.P. filed SCHEDULE 13G for Zevra Therapeutics, Inc. Common Stock, par value $0.0001 per share (ZVRA).
- Disclosed ownership: 6.8%.
- Date of event: 31 Dec 2024.
Adage Capital Management, L.P. - 31 Dec 2024 SCHEDULE 13G Report for Zevra Therapeutics, Inc. Common Stock, par value $0.0001 per share (ZVRA)
- Filing Manager
- Adage Capital Management, L.P.
- Reporting Manager
- Adage Capital Management, L.P.
- Symbol
- ZVRA
- Shares outstanding
- 53,362,573 shares
- Disclosed Ownership
- 3,650,000 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13G
- Filing time
- 12 Feb 2025, 09:32:25 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 13 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Adage Capital Management, L.P. disclosed 6.8% ownership in Zevra Therapeutics, Inc. Common Stock, par value $0.0001 per share (ZVRA) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 09:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Adage Capital Management, L.P. | 6.8% | 3,650,000 | 0 | 3,650,000 | /s/ Robert Atchinson | By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member | |
| Robert Atchinson | 6.8% | 3,650,000 | 0 | 3,650,000 | /s/ Robert Atchinson | Robert Atchinson, individually | |
| Phillip Gross | 6.8% | 3,650,000 | 0 | 3,650,000 | /s/ Phillip Gross | Phillip Gross, individually |